Do not miss the chance to join our hands-on XV Workshop of Theoretical-Practical Training in MRS / MRI, with specific application in laboratory animals
Our excellent teacher Dr. Silvia Lope will be at the helm in this practical workshop. And it provides all the required skills users need to operate our fantastic Biospec, available as a service in our Unit 25.
The registration period for the “XV Workshop of Theoretical-Practical Training in Spectroscopy and Magnetic Resonance Imaging (MRS / MRI): Application in Laboratory Animals” is still open until May the 17th, 2024. This workshop is organized by the Department of Biochemistry and Molecular Biology and the Nuclear Magnetic Resonance Service of the Autonomous University of Barcelona, and will take place from May 28 to 30, 2024.
The aim of this workshop is to serve as an introduction to the application of the Magnetic Resonance Imaging (MRI) technique in preclinical studies.
The aim of this workshop is to serve as an introduction to the application of the Magnetic Resonance Imaging (MRI) technique in preclinical studies. The fundamental theoretical concepts that allow understanding the operation of the technique will be explained, with special emphasis on practical application with small animals using our state of the art 7 Teslas Bruker Biospec spectrometer.
The workshop is aimed at students and researchers who want to get started in spectroscopy and magnetic resonance imaging techniques applied to laboratory animals.
How do I apply?
If you are interested, you can download the brochure and the registration form at https://tinyurl.com/XVpreclinicalMRIMRSworkshop. For registration, just submit the registration form back by e-mail to the following address: silvia.lope@uab.cat.
The number of participants is limited to 4 people, and there is one seat left. Do not miss this opportunity!
About NANBIOSIS:
The goal of NANBIOSIS is to provide comprehensive and integrated advanced solutions for companies and research institutions in biomedical applications. All of this is done through a single-entry point, involving the design and production of biomaterials, nanomaterials, and their nanoconjugates. This includes their characterization from physical-chemical, functional, toxicological, and biological perspectives (preclinical validation).
In order to access our Cutting-Edge Biomedical Solutions, place your request here.
NANBIOSIS has worked with pharmaceutical companies of all sizes in the areas of drug delivery, biomaterials and regenerative medicine. Here are a few of them:
